Open original FDA record ↗Recall record
- FDA identifier
- Z-0980-2024
- Company in FDA record
- Abiomed, Inc.
- FDA classification date
- Feb 9, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
IFU has been updated to include warnings about the risk of the inlet perforating through the myocardial wall of the left ventricle due to operator handling.
Source facts
- Action
- Firm notified affected consignees of the updated warnings in the IFU beginning on December 27, 2023. Customers were provided with details of the IFU modifications. Customers should notify everyone at their facility who needs to be informed of this correction. If products have been forwarded to another facility, please notify that facility of the updated IFUs. Post a copy of the recall notice in a visible area for awareness. If you have questions or concerns regarding this notice, please contact recallcoordinators@abiomed.com and/or your local clinical field staff.
- Initiated
- 2023-12-27
- Root cause
- Labeling Change Control
- Distribution
- Worldwide distribution - US Nationwide and the countries of AU, CA, DE, FR, IN, MX, TW, and VI.
- Recall number
- Z-0980-2024
- Recall status
- Open, Classified
- CDRH record ID
- 205357
- FDA classified
- 2024-02-09
- Recall event number
- 93749